Normal view MARC view ISBD view

POINT: should radiation dose from CT scans be a factor in patient care? Yes. [electronic resource]

By:

McCunney, Robert J

Producer: 20150616Description: 872-874 p. digitalISSN:

1931-3543

Subject(s):

Online resources:

Available from publisher's website

In: Chest vol. 147

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Editorial

There are no comments on this title.

to post a comment.

Back to results

1 Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.
by Jin, Chunyang
2 Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.
by Jin, Chunyang
3 Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.
by Jin, Chunyang
4 A rapid functional assay for the human trace amine-associated receptor 1 based on the mobilization of internal calcium.
by Navarro, Hernán A
5 Structure-activity correlations for beta-phenethylamines at human trace amine receptor 1.
by Lewin, Anita H
6 Amiodarone and its putative metabolites fail to activate wild type hTAAR1.
by Lewin, Anita H
7 Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.
by Jin, Chunyang
8 Aporphinoid antagonists of 5-HT2A receptors: further evaluation of ring A substituents and the size of ring C.
by Ponnala, Shashikanth
9 Highly potent and selective phenylmorphan-based inverse agonists of the opioid delta receptor.
by Thomas, James B
10 Identifying structural features on 1,1-diphenyl-hexahydro-oxazolo[3,4-a]pyrazin-3-ones critical for Neuropeptide S antagonist activity.
by Zhang, Yanan
11 (+/-)-Nantenine analogs as antagonists at human 5-HT(2A) receptors: C1 and flexible congeners.
by Chaudhary, Sandeep
12 Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter.
by Navarro, Hernán A
13 Evaluation of structural effects on 5-HT(2A) receptor antagonism by aporphines: identification of a new aporphine with 5-HT(2A) antagonist activity.
by Ponnala, Shashikanth
14 Short-term adolescent nicotine exposure in rats elicits immediate and delayed deficits in T-lymphocyte function: critical periods, patterns of exposure, dose thresholds.
by Navarro, Hernán A
15 Corrigendum to "A selective delta opioid receptor antagonist based on a stilbene core" [Bioorg. Med. Chem. Lett. 25 (2015) 5532-5535].
by Hartung, Alyssa M
16 Palladium-catalyzed transformations of salvinorin A, a neoclerodane diterpene from Salvia divinorum.
by Riley, Andrew P
17 A selective delta opioid receptor antagonist based on a stilbene core.
by Hartung, Alyssa M
18 New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine.
by Chaudhary, Sandeep
19 Affinity of aporphines for the human 5-HT2A receptor: insights from homology modeling and molecular docking studies.
by Pecic, Stevan
20 Stilbenes as κ-selective, non-nitrogenous opioid receptor antagonists.
by Hartung, Alyssa M